| 13:30 ~ 13:45 |
The Art of Selecting the Right Intensity: A Tailored Approach to Doublet and Triplet Therapies in mHSPC |
Silke GILLESSEN (Swiss) |
|
| 13:45 ~ 13:55 |
Beyond the Class Effect: A Clinician’s Guide to ARPI Selection and Toxicity Tailoring in mHSPC |
Joseph KIM (USA) |
|
| 13:55 ~ 14:05 |
Radiotherapy to the primary and metastasis-directed therapy: who benefits and how to integrate |
Jung Ki JO (Korea) |
|
| 14:05 ~ 14:15 |
Monitoring response and resistance: imaging, biomarkers, and when to change strategy |
Lukman HAKIM (Indonesia) |
|
| 14:15 ~ 14:40 |
Case-based discussion |
Moderator: Sang Hun SONG (Korea) Discussant: Dalsan YOU (Korea) Jae Seung CHUNG (Korea) Silke GILLESSEN (Swiss) Joseph KIM (USA) Jung Ki JO (Korea) Lukman HAKIM (Indonesia) |
|